ScoreWhy is Castle Biosciences, Inc. ?
1
The company has declared negative results in Mar'2025 after 7 consecutive positive quarters
- PRE-TAX PROFIT(Q) At USD -1.33 MM has Fallen at -116.84%
- NET PROFIT(Q) At USD 3.34 MM has Fallen at -62.58%
- DEBT-EQUITY RATIO (HY) Highest at -52.39 %
2
Risky - Negative Operating Profits
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 35.31%, its profits have risen by 86.4%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Castle Biosciences, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Castle Biosciences, Inc.
28.72%
1.14
63.24%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
40.82%
EBIT Growth (5y)
-232.95%
EBIT to Interest (avg)
-44.30
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.60
Sales to Capital Employed (avg)
0.61
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.15
EV to EBIT
-17.73
EV to EBITDA
8.54
EV to Capital Employed
1.38
EV to Sales
0.70
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.81%
ROE (Latest)
-0.95%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 69.17 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 12.8 times
-17What is not working for the Company
PRE-TAX PROFIT(Q)
At USD -1.33 MM has Fallen at -116.84%
NET PROFIT(Q)
At USD 3.34 MM has Fallen at -62.58%
DEBT-EQUITY RATIO
(HY)
Highest at -52.39 %
OPERATING PROFIT(Q)
Lowest at USD -0.84 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -0.97 %
Here's what is working for Castle Biosciences, Inc.
Operating Cash Flow
Highest at USD 69.17 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Inventory Turnover Ratio
Highest at 12.8 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for Castle Biosciences, Inc.
Pre-Tax Profit
At USD -1.33 MM has Fallen at -116.84%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD 3.34 MM has Fallen at -62.58%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Profit
Lowest at USD -0.84 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Operating Profit Margin
Lowest at -0.97 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Debt-Equity Ratio
Highest at -52.39 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
